Lincoln, NE (PRWEB) March 23, 2015
A case study by Healthcare Data Solutions (HDS), confirms that its Prescriber Validation Subscription Service (PVSS) solution helped pharmacies save millions in potential hydrocodone fines. The case study was conducted to observe the impact of the DEA’s change of hydrocodone combination drugs (HCPs) from Schedule III to Schedule II prior to and after the October 6, 2014 deadline. As a result of the schedule change, many prescribers who were previously authorized to write prescriptions for drugs such as Vicodin®, Lorcet® and Lortab® became ineligible under the new legislation. Pharmacies were also tasked with the dual responsibility of identifying newly ineligible prescribers and prohibiting refills of hydrocodone prescriptions written prior to October 6th. The study found that by using PVSS, Healthcare Data Solutions’ pharmacy customers successfully avoid financial fines ranging from $1 million - $10 million and prison terms up to 30 years.
Recognizing the ramifications of the schedule change for its pharmacy customers, Healthcare Data Solutions (HDS) took the initiative to help pharmacies prepare. Ninety days prior to the change, HDS sent Prescriber Validation Subscription Service (PVSS) customers a list of doctors who prescribed hydrocodone drugs, which enabled those pharmacies to flag prescribers after the change took effect. Additionally, by integrating timely updates from the Medi-Span® Controlled Substances File from Wolters Kluwer, HDS was also able to send PVSS clients warning and rejection messages ahead of schedule.
Prior to the schedule change, Prescriber Validation Subscription Service (PVSS) from Healthcare Data Solutions sent 259 warnings and rejection messages for problematic hydrocodone prescriptions. That number increased 20 times to 5,180, just weeks after the schedule change.
“This case study proves what an invaluable solution Prescriber Validation Subscription Service (PVSS) provides to pharmacy clients not only on a daily basis but also when regulatory changes arise,” said Miranda Rochol, Vice President of Product and Strategy at Healthcare Data Solutions. “With PVSS, our pharmacy clients are continuously assured that they can remain in compliance with new regulations as they occur – without any disruptions to regular business operations.”
To access Healthcare Data Solutions’ case study, visit: http://www.healthcaredatasolutions.com/wp-content/uploads/2012/04/Hydrocodone-Case-Study.pdf
About Healthcare Data Solutions:
Healthcare Data Solutions (HDS) is a leading healthcare information services company focused on building and maintaining the most accurate, compliance-grade data on Physicians, Dentists, Nurse Practitioners and other Healthcare Providers, as well as Pharmacies, Hospitals, Health Systems, ACOs, IDNs, GPOs and other Healthcare Organizations. Healthcare Data Solutions provides healthcare data, physician validation programs, data processing, compliance services, web services and new customer acquisition programs for leading healthcare firms. Compliance clients can access over 5 million healthcare provider profiles to crosswalk government databases for accurate reporting. Healthcare Data Solutions is the fastest growing healthcare data services company in the United States on both the Inc. 5000 and Deloitte Fast 500 list. For more information, visit http://www.HealthcareDataSolutions.com.